Auspex Pharmaceuticals
La Jolla, US · Founded 2007 · 2 known investors
Biotech
Founders & leadership
DA
David A. StamlerNamed on SEC filing
SS
Sepehr SarsharNamed on SEC filing
AS
Andreas SommerNamed on SEC filing
DC
David CollierNamed on SEC filing
PS
Pratik ShahNamed on SEC filing
SS
Samuel SaksNamed on SEC filing
LC
Lawrence C. FritzNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2011
▶$3MraisedJan 2012 · 7 investors · PharmaceuticalsRule 506(b)
▶$3MraisedJan 2012 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David A. StamlerExecutive Officer
- Sepehr SarsharDirector
- Andreas SommerExecutive Officer
- David CollierDirector
- Pratik ShahDirector
- Samuel SaksDirector
- Lawrence C. FritzExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $3M
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Auspex Pharmaceuticals's investors?
- Auspex Pharmaceuticals's investors include venBio Partners, Thomas, McNerney & Partners.
- How much funding has Auspex Pharmaceuticals raised?
- Auspex Pharmaceuticals has disclosed $3M raised across 1 round.
- Where is Auspex Pharmaceuticals headquartered?
- Auspex Pharmaceuticals is headquartered in La Jolla, US.